Abstract

BackgroundHeterogeneity in the definition and measurement of complex diseases in Genome-Wide Association Studies (GWAS) may lead to misdiagnoses and misclassification errors that can significantly impact discovery of disease loci. While well appreciated, almost all analyses of GWAS data consider reported disease phenotype values as is without accounting for potential misclassification.ResultsHere, we introduce Phenotype Latent variable Extraction of disease misdiagnosis (PheLEx), a GWAS analysis framework that learns and corrects misclassified phenotypes using structured genotype associations within a dataset. PheLEx consists of a hierarchical Bayesian latent variable model, where inference of differential misclassification is accomplished using filtered genotypes while implementing a full mixed model to account for population structure and genetic relatedness in study populations. Through simulations, we show that the PheLEx framework dramatically improves recovery of the correct disease state when considering realistic allele effect sizes compared to existing methodologies designed for Bayesian recovery of disease phenotypes. We also demonstrate the potential of PheLEx for extracting new potential loci from existing GWAS data by analyzing bipolar disorder and epilepsy phenotypes available from the UK Biobank. From the PheLEx analysis of these data, we identified new candidate disease loci not previously reported for these datasets that have value for supplemental hypothesis generation.ConclusionPheLEx shows promise in reanalyzing GWAS datasets to provide supplemental candidate loci that are ignored by traditional GWAS analysis methodologies.

Highlights

  • Heterogeneity in the definition and measurement of complex diseases in Genome-Wide Association Studies (GWAS) may lead to misdiagnoses and misclassification errors that can significantly impact discovery of disease loci

  • Phenotype Latent variable Extraction of disease misdiagnosis (PheLEx) compared to existing methods At present, there is only one existing misclassification framework designed for the analysis of GWAS data [49, 73, 77], referred to here as the “Rekaya” method or framework

  • As accuracy of misclassification probability under the misclassification model depends on estimated function of single nucleotide polymorphism (SNP) effects and typically most SNPs in a linkage disequilibrium (LD-) pruned GWAS dataset are not associated with the phenotype of interest, PheLEx filters out potentially uninformative SNPs by taking a subset of statistically significant GWAS genotypes as input, which provides significant advantages in terms of computational expense and accuracy in identifying misclassified samples

Read more

Summary

Introduction

Heterogeneity in the definition and measurement of complex diseases in Genome-Wide Association Studies (GWAS) may lead to misdiagnoses and misclassification errors that can significantly impact discovery of disease loci. Shafquat et al BMC Bioinformatics (2020) 21:178 interactions [25,26,27,28], as well as methods aimed to extract impact of loci with rare variants [29,30,31,32,33] Together, these innovations in GWAS design and methodology have led to discovery of candidate loci where impact is noticeable in diseases such as type 2 diabetes and schizophrenia where large-scale consortium studies have enabled isolation of numerous causal loci with low frequency and small effects [2, 34,35,36,37]. Methods that could reliably identify cases of misclassification in GWAS could be a promising approach for improving candidate loci discovery in GWAS, when considering the potential for immediate impact and implementation at minimal cost

Methods
Results
Discussion
Conclusion

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call

Disclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.